Protocol: L034K
______________________________________________________________________________
| 582 |L04AA12| INFLIXIMABUM**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg
SOL. PERF.
REMICADE 100 mg 100 mg CENTOCOR B.V.
________________________________________________________________________________
______________________________________________________________________________
| 583 |L04AA17| ADALIMUMABUM**** | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg
PREUMPLUTĂ
HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD.
________________________________________________________________________________
SUBLISTA C1 - G31B POLIARTRITĂ REUMATOIDĂ.
Dostları ilə paylaş: | 
